Chemical effects in biological systems (CEBS) object model for toxicology data, SysTox-OM: Design and application

Bioinformatics

Volumn 22, Issue 7, 2006, Pages 874-882

  Xirasagar, Sandhya ^a   Gustafson, Scott F ^a   Huang, Cheng Cheng ^a   Pan, Qinyan ^a   Fostel, Jennifer ^c   Boyer, Paul ^a   Merrick, B Alex ^b   Tomer, Kenneth B ^b   Chan, Denny D ^a   Yost III, Kenneth J ^a   Choi, Danielle ^d   Xiao, Nianqing ^a   Stasiewicz, Stanley ^b   Bushel, Pierre ^b   Waters, Michael D ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c LOCKHEED MARTIN   (United States)

^d RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ACCURACY; ARTICLE; CLINICAL CHEMISTRY; COMPUTER PROGRAM; DATA ANALYSIS; GENE EXPRESSION; HISTOPATHOLOGY; INFORMATION PROCESSING; INFORMATION SYSTEM; INTERNET; METABOLOMICS; METHODOLOGY; MOLECULAR WEIGHT; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN DATABASE; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN PROTEIN INTERACTION; PROTEOMICS; STRESS; TOXICOGENETICS; TOXICOLOGY; TRANSCRIPTOMICS;

ANIMALIA;

EID: 33645297107     PISSN: 13674803     EISSN: 13674811     Source Type: Journal    
DOI: 10.1093/bioinformatics/btk045     Document Type: Article

References (13)

1. Amin,R.P. et al. (2002) Genomic interrogation of mechanism(s) underlying cellular responses to toxicants. Toxicology, 181-182, 555-563.
2. Brazma,A. et al. (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet., 29, 365-371.
3. Duclos-Cartolano,C. and Venot,A. (2003) Building and evaluation of a structured representation of pharmacokinetics information presented in spcs: From existing conceptual views of pharmacokinetics associated with natural language processing to object-oriented design. J. Am. Med. Informat. Assoc., 10, 271-280.
4. Fostel,J. et al. (2005) Chemical effects in biological systems - data dictionary (CEBS-DD) for the Capture and integration of biological study design description, conventional phenotypes and 'omics data. Toxicol. Sci., 88, 585-601.
5. Gant,T.W. and Zhang,S.D. (2005) In pursuit of effective toxicogenomics. Mutat. Res., 575, 4-16.
6. Lord,P.G. (2004) Progress in applying genomics in drug development. Toxicol. Lett., 149, 371-375.
7. Mattes,W.B. et al. (2004) Database development in toxicogenomics: Issues and efforts. Environ. Health Perspect., 112, 495-505.
8. Merrick,B.A. and Tomer,K.B. (2003) Toxicoproteomics: A parallel approach to identifying biomarkers. Environ. Health Perspect., 111, A578-A579.
9. Rumbaugh,J., Booch,G. and Jacobson,I. (eds). Unified Modelling Language Reference Manual. Addision-Wesley Longman, Massachusetts.
10. Sawada,H. et al. (2005) A toxicogenomic approach to drug-induced phospholipidosis: Analysis of its induction mechanism and establishment of a novel in vitro screening system. Toxcol. Sci., 83, 282-292.
11. Sansone,S.A. et al. (2004) Standardization initiatives in the (eco)toxicogenomics domain: A review. J. Comp. Funct. Genom., 5, 633-641.
12. Waters,M. and Fostel,J.M. (2004) Toxicogenomics and systems toxicology: aims and prospects. Nat. Rev. Genet., 5, 936-948.
13. Xirasagar,S. et al. (2004) CEBS object model for systems biology data, SysBio-OM. Bioinformatics, 20, 2004-2015.